SIM Acquisition Corp. I Class A Ordinary Shares logo

SIM Acquisition Corp. I Class A Ordinary Shares(SIMA)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$10.97
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for SIMA

11/13/2026: SIMA (1-star) is currently NOT-A-BUY. Pass it for now.

SIM Acquisition Corp. I is a special purpose acquisition company (SPAC) currently focused on transitioning from a shell company to an operating business. Its primary strength lies in an experienced management team dedicated to securing a healthcare-related acquisition. The investment story centers on the potential merger with American Industrial Technologies, which represents a critical step in the company's objective. Investors face significant risks, including the uncertainty of final merger execution, regulatory hurdles, and the impact of shareholder redemptions. Given its nature as a pre-revenue entity, this stock is generally suited for speculative investors who understand the risks of SPAC structures and are monitoring the progress toward deal completion.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitThe company offers growth potential only if a successful acquisition of a high-growth company is completed.
Momentum investorWeak fitThis is a pre-operating entity, and momentum is typically limited unless news regarding a definitive merger emerges.
Value investorMixed fitValue may be found if shares trade at a discount to the trust value, but there is no underlying asset to value yet.
Dividend investorWeak fitThe company pays no dividends and does not have an operating business to support payouts.
Low-risk investorWeak fitSPAC investments involve significant uncertainty regarding the outcome of the target acquisition.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highSPAC prices often fluctuate significantly based on news, rumors, and proximity to merger deadlines.
Valuation riskHighThere is no current operating business, making it impossible to apply standard valuation models.
Competition risk (Target search)HighThe firm competes with many other SPACs for a limited number of high-quality private healthcare companies.
Business qualityMediumThe final business quality is unknown until a definitive acquisition target is chosen and disclosed.
Dividend incomeLow / noneThe company has no revenue and generates no income to distribute as dividends.
Execution riskHighSuccess depends on the team's ability to negotiate a merger and gain shareholder approval within a fixed timeframe.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 90.20M USD
Price to earnings Ratio 45.73
1Y Target Price -
Price to earnings Ratio 45.73
1Y Target Price -
Volume (30-day avg) 2.9K shares
Beta 0.01
52 Weeks Range 10.10 - 12.90
Updated Date 11/14/2026
52 Weeks Range 10.10 - 12.90
Updated Date 11/14/2026
Dividends yield (FY) -
Basic EPS (TTM) 0.24

Sector & Industry Intelligence

Sector

Financial Services

Constructive
Sentiment
Bullish
Momentum
BUY Breadth Improving
BUY participation
50.4%
Active BUY / eligible
61 / 121
30-Day BUY Count Change
+45
Market state
Bullish

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Shell Companies

BUY participation
100.0%
Active BUY / eligible
1 / 1
30-Day BUY Count Change
+1

Eligible universe: 1 stock.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Flat / Range-Bound
PRICE PATH

Flat / Range-Bound

The stock price has been trading within a narrow range with minimal directional movement.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit 6.79%
Avg. Invested days 178
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 2.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
SIMA receives a 2-star rating, reflecting soft or weak scores across the available pillars. The rating is constrained by weak unit economics, soft analyst coverage, and weak price momentum.

Company Fundamentals

★★★★★
SIMA has moderate overall fundamentals (3 stars), with moderate financial health, moderate growth momentum, and solid ownership. In FY2025 versus FY2024, strong earnings growth (+85.2%) is partially offset by soft cash generation (FCF margin 0.0%), slightly negative revenue growth (+0.0%), soft profitability (net margin 0.0%).

Financial Health Rating

★★★★★
SIMA's financial health is supported by strong efficiency, including operating-expense and cost-of-revenue discipline (opex 0.0% of revenue). Profitability is weak (1 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Earnings growth is SIMA's strongest growth driver at +85.2% FY2025 versus FY2024 (strong, 5 stars). By comparison, free-cash-flow growth (+25.2%, solid) is also solid, while revenue growth (+0.0%, slightly negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 45.3% and approximately 15.6% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 84.44% supports management-shareholder alignment.

Top 5 Institutional Investors

Meteora Capital, LLC 1.29%
Mizuho Securities USA Inc 1.01%
DLD Asset Management, LP 0.73%
Kepos Capital LP 0.37%
Geode Capital Management, LLC 0.19%

Unit Economics (Per $1K Revenue)

★★★★★
SIMA generates approximately $0 of gross profit, $-0 of operating income, and $-0 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Weak margins explain the 1-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 0.00%

Quantitative Style Profile

★★★★★
SIMA has a relatively low-volatility profile. Weak momentum is the primary drawback, while soft valuation.

Style Classification

Quality Focused

Low VolatilitySmall / Mid Cap Risk

How Company Makes Money

Business areaWhat it includesRetail investor read
Financial Services / Interest IncomeInterest earned on the capital held in the company's trust account.This company does not sell products; it earns a small amount of interest until it buys a real company.

Valuation

Trailing PE 45.73
Forward PE -
Enterprise Value 90.64M
Price to Sales(TTM) -
Enterprise Value 90.64M
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding 3.55M
Shares Floating 552.76K
Shares Outstanding 3.55M
Shares Floating 552.76K
Percent Insiders 84.44
Percent Institutions 45.3

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.